APA

Bourdette D. N., Edmonds E., Smith C., Bowen J. D., Guttmann C. R. G., Nagy Z. P., Simon J., Whitham R., Lovera J., Yadav V., Mass M., Spencer L., Culbertson N., Bartholomew R. M., Theofan G., Milano J., Offner H. & Vandenbark A. A. (20051108). A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Bourdette D N, Edmonds E, Smith C, Bowen J D, Guttmann C R G, Nagy Z P, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew R M, Theofan G, Milano J, Offner H and Vandenbark A A. 20051108. A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Bourdette D. N., Edmonds E., Smith C., Bowen J. D., Guttmann C. R. G., Nagy Z. P., Simon J., Whitham R., Lovera J., Yadav V., Mass M., Spencer L., Culbertson N., Bartholomew R. M., Theofan G., Milano J., Offner H. and Vandenbark A. A. (20051108). A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Bourdette D N, Edmonds E, Smith C, Bowen J D, Guttmann C R G, Nagy Z P, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew R M, Theofan G, Milano J, Offner H and Vandenbark A A. A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England). 20051108.